制藥網(wǎng)>產(chǎn)品庫>原料藥中間體、制劑>生物試劑>其它試劑>>Recombinant PEDF貨號:130-13 細胞因子

Recombinant PEDF貨號:130-13 細胞因子

參考價	面議

參考價

面議

具體成交價以合同協(xié)議為準

公司名稱北京方程嘉鴻科技有限公司
品牌
型號
所在地北京市
廠商性質(zhì)生產(chǎn)廠家
更新時間2016/2/12 18:19:06
訪問次數(shù)10258

產(chǎn)品標簽:

Recombinant PEDF 貨號:130-13 細胞因子

在線詢價收藏產(chǎn)品查看電話同類產(chǎn)品

聯(lián)系我們時請說明是制藥網(wǎng) 上看到的信息，謝謝!

索取相關(guān)資料

公司介紹主營產(chǎn)品

北京方程嘉鴻科技有限公司是一家專業(yè)經(jīng)營生物、儀器、試劑耗材的公司，在廣大用戶的幫助和支持下，經(jīng)過不懈的努力，已成為國內(nèi)生命科學領(lǐng)域產(chǎn)品的主要供應商之一，代理許多*水平的高科技產(chǎn)品，包括分子生物學、細胞生物學、免疫學、診斷等多個研究及應用領(lǐng)域。公司的服務和業(yè)務網(wǎng)絡遍及全國，在同行獲得*好評。

展開顯示更多內(nèi)容

ELISA試劑盒,北京ELISA代測,elisa價格,elisa品牌,人elisa試劑盒

產(chǎn)品簡介在線詢價

Recombinant PEDF 貨號:130-13 細胞因子
細胞因子(cytokine,CK)是一類能在細胞間傳遞信息、具有免疫調(diào)節(jié)和效應功能的蛋白質(zhì)或小分子多肽。
作用特點：多效性、重疊性、協(xié)同性、拮抗性和雙重性。

Recombinant PEDF貨號:130-13 細胞因子產(chǎn)品信息

Recombinant PEDF 貨號:130-13 細胞因子

胞因子受體存在著可溶性形式，掌握可溶性細胞因子受體產(chǎn)生的規(guī)律及其生理和病理意義，必將擴展人們對細胞因子網(wǎng)絡作用的認識。檢測細胞因子及其受體的水平已成為基礎(chǔ)和臨床免疫學研究中的一個重要的方面。Catalog Number:

Catalog Number:

130-13

Synonyms:

Pigment epithelium-derived factor, SerpinF1, EPC-1

Description:

PEDF is a noninhibitory serpin with neurotrophic, anti-angiogenic, and anti-tumorigenic properties. It is a 50 kDa glycoprotein produced and secreted in many tissues throughout the body. A major component of the anti-angiogenic action of PEDF is the induction of apoptosis in proliferating endothelial cells. In addition, PEDF is able to inhibit the activity of angiogenic factors such as VEGF and FGF-2. The neuroprotective effects of PEDF are achieved through suppression of neuronal apoptosis induced by peroxide, glutamate, or other neurotoxins. The recent identification of a lipase-linked cell membrane receptor for PEDF （PEDF-R） that binds to PEDF with high affinity （1） should facilitate further elucidation of the underlying mechanisms of this pluripotent serpin. To date, PEDF-R is the only signaling receptor known to be used by a serpin family member. The unique range of PEDF activities implicate it as a potential therapeutic agent for the treatment of vasculature related neurodegenerative diseases such as age-related macular degeneration （AMD） and proliferative diabetic retinopathy （PDR）. PEDF also has the potential to be useful in the treatment of various angiogenesis-related diseases including a number of cancers. Recombinant PEDF is a 44.5 kDa non-glycosylated protein containing 400 amino acid residues. （1） Notari, I. et al. J Biol Chem., Vol. 281, 38022-38037.

AA Sequence:

MQNPASPPEE GSPDPDSTGA LVEEEDPFFK VPVNKLAAAV SNFGYDLYRV RSSMSPTTNV LLSPLSVATA LSALSLGAEQ RTESIIHRAL YYDLISSPDI HGTYKELLDT VTAPQKNLKS ASRIVFEKKL RIKSSFVAPL EKSYGTRPRV LTGNPRLDLQ EINNWVQAQM KGKLARSTKE IPDEISILLL GVAHFKGQWV TKFDSRKTSL EDFYLDEERT VRVPMMSDPK AVLRYGLDSD LSCKIAQLPL TGSMSIIFFL PLKVTQNLTL IEESLTSEFI HDIDRELKTV QAVLTVPKLK LSYEGEVTKS LQEMKLQSLF DSPDFSKITG KPIKLTQVEH RAGFEWNEDG AGTTPSPGLQ PAHLTFPLDY HLNQPFIFVL RDTDTGALLF IGKILDPRGP

Source:

E.coli

Purity:

Greater than 90% by SDS-PAGE gel and HPLC analyses.

Biological Activity:

Data Not Available.

Research Interests: